Teniposide (WG Critical Care, LLC)
Welcome to the PulseAid listing for the Teniposide drug offered from WG Critical Care, LLC. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | WG Critical Care, LLC |
| NON-PROPRIETARY NAME: | Teniposide |
| SUBSTANCE NAME: | TENIPOSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
Teniposide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Teniposide from WG Critical Care, LLC |
| LABELER NAME: | WG Critical Care, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44567-507_82247827-8839-456f-be47-0593ebf13214 |
| PRODUCT NDC: | 44567-507 |
| APPLICATION NUMBER: | NDA020119 |
Other TENIPOSIDE Pharmaceutical Manufacturers / Labelers:
